4 days ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial …

4 days ago · Lilly reports full Q4 2024 financial results and provides 2025 guidance Published. Feb 6, 2025 6:45am EST. Revenue in Q4 2024 increased 45% to $13.53 billion driven by …

5 days ago · Lilly reports full Q4 2024 financial results and provides 2025 guidance. PR Newswire. INDIANAPOLIS, Feb. 6, 2025. Revenue in Q4 2024 increased 45% to $13.53 billion driven by …

Search Lilly.com For Content... Quarterly Results Quarterly Results ... Q4 Earnings Earnings Call. Press Release 212.1 KB. Earnings Presentation 2.8 MB. Q4 2023 Financial Workbook 81.6 …

4 days ago · Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue (i) grew by 20% compared to Q4 2023.; …

4 days ago · Image source: The Motley Fool. Eli Lilly (NYSE: LLY) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...

3 days ago · Eli Lilly and Co reported a 32% increase in full-year revenue for 2024, exceeding guidance by $4 billion. The company achieved a 45% revenue growth in Q4 2024, driven by …

Jan 14, 2025 · For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 …

4 days ago · Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 …

4 days ago · In Q4 2024, worldwide revenue was $13.53 billion, an increase of 45% compared with Q4 2023, driven by a 48% increase in volume, partially offset by a 4% decrease due to …